Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,614.00
(
0.14%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rstor1

Send PM Follow Ignore
Followers 13
Posts 757
Boards Moderated 0
Alias Born 10/25/2003

rstor1

Re: DewDiligence post# 1799

Wednesday, 04/14/2004 7:48:25 AM

Wednesday, April 14, 2004 7:48:25 AM

Post# of 257266
CJC

+++The company concedes that nausea can be a limiting factor on dosing, and this is troubling from a competitive standpoint. +++

Garren says that nausea is a feature of every GLP1 therapy, FWIW.

Bob


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today